Results 111 to 120 of about 138,873 (259)
Background and Objectives: Pap smear is a screening test for diagnosing cervical cancer in females. It is considered a health-promotion exam, and it has been shown that this test can prevent up to %60 of all deaths resulting from cervical cancer.
Siamak Mohebi* +3 more
doaj +1 more source
Is the Incidence of Early‐Onset Adenocarcinomas in Aotearoa New Zealand Increasing?
There is a rising incidence of early‐onset adenocarcinomas in Aotearoa New Zealand which is site‐specific. This includes breast, colorectal, uterine, and prostate adenocarcinomas in the total population and colorectal, uterine, and lung adenocarcinomas in the Māori population.
Raymond Phang +5 more
wiley +1 more source
ABSTRACT Background Stage II endometrial cancer comprises 5% to 10% of cases and is pathologically diverse. Retrospective data guides recommendations which suggest surgical staging with adjuvant therapy, but the role of radical surgery and lymphadenectomy is uncertain, due to conflicting outcomes.
Jonathan Sandeford +2 more
wiley +1 more source
The COVID‐19 pandemic has shown that colposcopy services are vulnerable to a global health crisis. Increasing cervical cancer screening coverage is crucial to mitigate the reduction in colposcopy and cervical cancer prevention services during global health emergencies.
Giovanni Delli Carpini +5 more
wiley +1 more source
Caracterización de mujeres de Las Tunas con lesiones cérvico uterinas
Fundamento: el cáncer cérvico uterino provoca anualmente la muerte de muchas mujeres a nivel mundial, la mayoría en los países en desarrollo.Objetivo: caracterizar a las pacientes estudiadas por lesiones cérvico uterinas, atendidas en el Hospital General
Rabiel Cárdenas Peña +4 more
doaj
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Large Cell Neuroendocrine Carcinoma of the Cervix With Extensive Metastases
The Kaohsiung Journal of Medical Sciences, EarlyView.
Di‐Ping Yu, Li‐Mei Sun
wiley +1 more source
Low‐Density Lipoprotein Receptor‐Related Protein 11 Promotes Proliferation in Lung Adenocarcinoma
This study demonstrates that LRP11 promotes lung adenocarcinoma progression by enhancing cell proliferation and modulating gene expression. High LRP11 expression was associated with poor prognosis, suggesting its potential as a therapeutic target and prognostic biomarker.
Takumi Kiwaki +7 more
wiley +1 more source
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix
Small cell neuroendocrine carcinoma of the cervix (SCNEC), a rare but aggressive cancer, consistently exhibited high VRK1 expression. VRK1 knockdown significantly suppressed xenograft tumor growth by inducing mitochondrial dysfunction. These findings highlighted VRK1 as a potential therapeutic target for SCNEC.
Mariya Kobayashi +16 more
wiley +1 more source

